Goldman Sachs
CBST

Goldman Sachs’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Goldman Sachs’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-15,800
Closed -$1.59M – 7571
2014
Q4 		$1.59M Buy
15,800
+1,700
+12% +$132K ﹤0.01% 4087
2014
Q3 		$935K Sell
14,100
-1,000
-7% -$65.7K ﹤0.01% 4680
2014
Q2 		$1.05M Sell
15,100
-2,100
-12% -$143K ﹤0.01% 4642
2014
Q1 		$1.26M Sell
17,200
-51,100
-75% -$3.81M ﹤0.01% 4439
2013
Q4 		$4.7M Sell
68,300
-79,400
-54% -$5.14M ﹤0.01% 3145
2013
Q3 		$9.39M Buy
147,700
+96,700
+190% +$5.84M ﹤0.01% 2320
2013
Q2 		$2.46M Buy
+51,000
New +$2.51M ﹤0.01% 3505

Goldman Sachs's CBST Position: Q1 2015 in Review

Goldman Sachs sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 284,911 shares — an estimated $28.7M sold.

Goldman Sachs first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $35.8M in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Goldman Sachs reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Goldman Sachs sold 284,911 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $28.7M.
  • Goldman Sachs first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Goldman Sachs's CUBIST PHARMACEUTICALS INC position peaked at $35.8M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.